BOSTON, Massachusetts, Oct. 19 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * ADC Improves Outcomes for Patients with Advanced Triple-Negative Breast Cancer Who are Ineligible for Immune Checkpoint Inhibitors * Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govi  more

LONDON, England, Oct. 18 -- The University College London issued the following news: * * * Landmark gene therapy study shows safety for children Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment. An international team of researchers led by Great Ormond Street Hospital (GOSH), University College London (UCL), and University of California, Los Angles (UCLA) develop  more